XML 58 R49.htm IDEA: XBRL DOCUMENT v3.19.2
DEBT (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended 12 Months Ended
May 12, 2018
May 12, 2017
May 05, 2017
Apr. 10, 2017
Mar. 16, 2017
Aug. 04, 2016
Jun. 24, 2019
May 28, 2019
Oct. 17, 2018
May 31, 2018
Mar. 23, 2017
Mar. 20, 2017
Nov. 16, 2015
Jun. 30, 2019
Dec. 20, 2018
Dec. 31, 2017
Dec. 31, 2018
Mar. 31, 2018
Nov. 16, 2017
Jul. 31, 2017
Jan. 31, 2017
Dec. 31, 2016
Nov. 30, 2016
Oct. 31, 2016
Sep. 30, 2016
Sep. 13, 2016
Convertible notes payable, principal amount                           $ 2,919,286                        
Debt outstanding amount                           2,599,229     $ 1,514,583                  
Debt discount                           3,169,672     3,350,000                  
Amortization of debt discount                           3,124,058                        
TFF [Member]                                                    
Short term debt borrowing capacity                           $ 15,000,000                        
Libor rate description                           (i) all lending in U.S. dollars is the one-month LIBOR plus six (6%) percent margin; and (ii) for all lending in Euro, the one-month Euribor Rate plus six (6%) percent per annum, commencing June 1, 2018                        
CEO [Member]                                                    
Percentage of wholly-owned subsidiary shares                           51.00%                        
Trade Facility Agreements [Member]                                                    
Debt outstanding amount                                   $ 5,866,910                
Payment of interest and principal                   $ 1,123,600                                
On April 18, 2018 [Member]                                                    
Maturity date                           Dec. 31, 2021                        
Debt outstanding amount                           $ 3,078,442     3,078,442                  
Accrued interest                           $ 515,519     414,830                  
Libor rate description                           Additionally the interest rate was amended such that the interest rate for all advances is 4% plus the 3-Month Libor rate                        
Gain on debt settlement                           $ 23,354                        
Loan Facility July 6, 2017 [Member]                                                    
Fees forgiven related to advance                           $ 40,000                        
SkyPharm [Member] | Trade Facility Agreements [Member]                                                    
Short term debt borrowing capacity   $ 2,274,800                                                
Debt outstanding amount                   $ 5,369,678                                
Description for the repayment   The total facility will be calculated as 95% of the agreed upon value of Decahedrons receivables.                                                
Term of credit facility   12 months                                                
Credit facility origination fee, percentage   2.00%                                                
Monthly credit fee, percentage   1.00%                                                
Proceeds from debt $ 247,117                                                  
SkyPharm [Member] | Trade Facility Agreements [Member] | Minimum [Member]                                                    
Short term debt borrowing capacity                                     $ 2,291,200              
SkyPharm [Member] | Trade Facility Agreements [Member] | Maximum [Member]                                                    
Short term debt borrowing capacity                                     $ 6,873,600              
Grigorios Siokas [Member]                                                    
Interest rate                             4.70%                      
Shares issued for settlement of debt             73,334 66,667           140,001                        
Synthesis facility agreement [Member] | TFF [Member]                                                    
Debt outstanding amount                 $ 5,629,555                                  
Accrued interest                 $ 524,094                                  
Description for amendment to agreement under ASU 470-50                 The Company evaluated the amended agreement under ASC 470-50 and concluded that it did not meet the 10% cash flow test and recorded debt modification expense of $138,110                                  
Debt modification expense                 $ 138,110                                  
Synthesis facility agreement [Member] | Principal balance 1 [Member] | TFF [Member]                                                    
Maturity date                 Aug. 31, 2021                                  
Accrued interest                           $ 0     0                  
Debt split, balance                 $ 2,000,000         2,274,800     2,291,200                  
Interest rate description                 6% per annum plus one-month Euribor, when it is positive, on the Euro balance                                  
Repayment of debt, periodic payments                 $ 125,000                                  
Frequency of periodic payments                 Quarterly                                  
Synthesis facility agreement [Member] | Principal balance 2 [Member] | TFF [Member]                                                    
Maturity date                 Aug. 31, 2021                                  
Accrued interest                           16,963     19,834                  
Debt split, balance                 $ 4,000,000         4,000,000     4,000,000                  
Interest rate description                 6% per annum plus one month Libor on the USD balance                                  
Repayment of debt, periodic payments                 $ 150,000                                  
Frequency of periodic payments                 Quarterly                                  
MediHelm S.A. [Member] | SkyPharm [Member]                                                    
Amortization of debt discount                           66,227   $ 69,269                    
Origination fees                           137,063                        
Senior Promissory Notes [Member] | Unaffiliated Third Party [Member] | April 9, 2019 [Member]                                                    
Convertible notes payable, principal amount                           $ 250,000                        
Repayment of debt description                           The Company may prepay the Note within the first six (6) months by payment of unpaid interest for the first six (6) months and after six (6) months, with a two (2%) percent ($5,000) premium.                        
Interest rate                           15.00%                        
Maturity date                           Apr. 09, 2020                        
Debt outstanding amount                           $ 250,000                        
Accrued interest                           8,527                        
Due from related party                           500,000                        
Senior Promissory Notes [Member] | Unaffiliated Third Party [Member] | April 3, 2019 [Member]                                                    
Convertible notes payable, principal amount                           $ 250,000                        
Repayment of debt description                           The Company may prepay the Notes within the first six (6) months by payment of unpaid interest for the first six (6) months interest and after six (6) months, with a (2%) percent ($5,000) premium on each note.                        
Interest rate                           15.00%                        
Maturity date                           Apr. 03, 2020                        
Debt outstanding amount                           $ 250,000                        
Accrued interest                           9,246                        
Senior Promissory Notes [Member] | Unaffiliated Third Party [Member] | April 1, 2019 [Member]                                                    
Convertible notes payable, principal amount                           $ 250,000                        
Repayment of debt description                           The Company may prepay the Notes within the first six (6) months by payment of unpaid interest for the first six (6) months interest and after six (6) months, with a (2%) percent ($5,000) premium on each note.                        
Interest rate                           15.00%                        
Maturity date                           Apr. 01, 2020                        
Debt outstanding amount                           $ 250,000                        
Accrued interest                           9,246                        
Loan Agreement [Member] | Panagiotis Drakopoulos [Member]                                                    
Short term debt borrowing capacity                         $ 42,832                          
Interest rate                         6.00%                          
Maturity date                         Nov. 15, 2016                          
Debt outstanding amount                           14,786     14,893                  
Accrued interest                           4,290     3,538                  
Loan facility agreement [Member]                                                    
Debt discount                           191,034                        
Unamortized debt discount                           20,237                        
Loan facility agreement [Member] | SkyPharm [Member]                                                    
Short term debt borrowing capacity           $ 1,292,769                                        
Interest rate           10.00%                                        
Description for the repayment           The amounts owed under the Loan Facility were repayable upon the earlier of (i) three months following the demand of the lender; or (ii) August 31, 2018. No prepayment is permitted pursuant to the terms of the Loan Facility                                        
Loan facility agreement [Member] | Grigorios Siokas [Member] | Synthesis facility agreement [Member]                                                    
Common stock shares issuable upon conversion of debt/convertible securities           10,000,000                                        
Amendment to loan facility agreement [Member] | SkyPharm [Member]                                                    
Short term debt borrowing capacity                                                   $ 1,533,020
Debt outstanding amount                                                   $ 240,251
Second amendment to loan facility agreement [Member] | SkyPharm [Member]                                                    
Short term debt borrowing capacity                     $ 2,664,960         70,000       $ 382,327 $ 155,516 $ 452,471 $ 250,000 $ 100,000 $ 174,000  
Interest rate                     10.00%                              
Maturity date                     Aug. 04, 2016                              
Debt outstanding amount                               3,117,287                    
Accrued interest                               221,657                    
Description for the repayment                     The amounts owed under the Loan Facility shall be repayable upon the earlier of (i) seventy five days following the demand of the Lender; or (ii) August 31, 2018                              
Common stock shares issuable upon conversion of debt/convertible securities                     1,000,000                              
Debt discount                               $ 42,149           $ 126,624        
Bridge Loans [Member] | SkyPharm [Member]                                                    
Short term debt borrowing capacity     $ 34,745   $ 50,000             $ 120,220   50,000                        
Interest rate     10.00%   10.00%             10.00%                            
Maturity date     Sep. 30, 2017   Apr. 16, 2017             Apr. 20, 2017                            
Amended maturity date         May 16, 2017             May 20, 2017                            
Debt outstanding amount         $ 50,000             $ 106,542   106,542                        
Accrued interest         $ 14,138             16,857   22,425                        
Gain on debt settlement                       19,695                            
Additional gain on settlement of debt                       4,668                            
Loan fixed payoff amount                       $ 106,542                            
Bridge Loans [Member] | SkyPharm [Member] | May 5 2017 [Member]                                                    
Debt outstanding amount                           34,745     34,745                  
Accrued interest                           $ 5,043     $ 3,906                  
Decahedron [Member] | SkyPharm [Member] | Trade Facility Agreements [Member]                                                    
Short term debt borrowing capacity       $ 3,127,850                                            
Description for the repayment       The total facility will be calculated as 95% of the agreed upon value of Decahedrons receivables                                            
Term of credit facility       12 months                                            
Credit facility origination fee, percentage       2.00%                                            
Monthly credit fee, percentage       1.00%                                            
Marathon [Member]                                                    
Distribution and equity acquisition agreement, description                           As consideration for its services, Company received: (a) a 33 1/3% equity interest or 5 million shares in Marathon as partial consideration for the Company’s distribution services; and (b) received cash of CAD $2,000,000, subject to repayment in Common Shares of the Company if it fails to meet certain performance milestones. The Company is entitled to receive an additional CAD $2,750,000 upon the Company’s receipt of gross sales of CAD $6,500,000 and an additional CAD $2,750,000 upon receipt of gross sales of CAD $13,000,000.                        
Settlement amount                           $ 1,554,590                        
Cash received                           $ 2,000,000                        
Shares issued for settlement of debt                           446,311